Kwan Edwin P, Xie Li, Sheu Laura, Ohtsuka Toshihisa, Gaisano Herbert Y
Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
Diabetes. 2007 Oct;56(10):2579-88. doi: 10.2337/db06-1207. Epub 2007 Jul 16.
Glucagon-like peptide-1 (GLP-1) rescues insulin secretory deficiency in type 2 diabetes partly via cAMP actions on exchange protein directly activated by cAMP (Epac2) and protein kinase A (PKA)-activated Rab3A-interacting molecule 2 (Rim2). We had reported that haplodeficient Munc13-1(+/-) mouse islet beta-cells exhibited reduced insulin secretion, causing glucose intolerance. Munc13-1 binds Epac2 and Rim2, but their functional interactions remain unclear.
We used Munc13-1(+/-) islet beta-cells to examine the functional interactions between Munc13-1 and Epac2 and PKA. GLP-1 stimulation of Munc13-1(+/-) islets normalized the reduced biphasic insulin secretion by its actions on intact islet cAMP production and normal Epac2 and Rim2 levels.
To determine which exocytotic steps caused by Munc13-1 deficiency are rescued by Epac2 and PKA, we used patch-clamp capacitance measurements, showing that 1) cAMP restored the reduced readily releasable pool (RRP) and partially restored refilling of a releasable pool of vesicles in Munc13-1(+/-) beta-cells, 2) Epac-selective agonist [8-(4-chloro-phenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate] partially restored the reduced RRP and refilling of a releasable pool of vesicles, and 3) PKA blockade by H89 (leaving Epac intact) impaired cAMP ability to restore the RRP and refilling of a releasable pool of vesicles. Conversely, PKA-selective agonist (N(6)-benzoyladenosine-cAMP) completely restored RRP and partially restored refilling of a releasable pool of vesicles. To determine specific contributions within Epac-Rim2-Munc13-1 interaction sites accounting for cAMP rescue of exocytosis caused by Munc13-1 deficiency, we found that blockade of Rim2-Munc13-1 interaction with Rim-Munc13-1-binding domain peptide abolished cAMP rescue, whereas blockade of Epac-Rim2 interaction with Rim2-PDZ peptide only moderately reduced refilling with little effect on RRP.
cAMP rescue of priming defects caused by Munc13-1 deficiency via Epac and PKA signaling pathways requires downstream Munc13-1-Rim2 interaction.
胰高血糖素样肽-1(GLP-1)部分通过环磷酸腺苷(cAMP)作用于环磷酸腺苷直接激活的交换蛋白(Epac2)和蛋白激酶A(PKA)激活的Rab3A相互作用分子2(Rim2)来挽救2型糖尿病中的胰岛素分泌缺陷。我们曾报道单倍体不足的Munc13-1(+/-)小鼠胰岛β细胞表现出胰岛素分泌减少,导致葡萄糖不耐受。Munc13-1与Epac2和Rim2结合,但其功能相互作用仍不清楚。
我们使用Munc13-1(+/-)胰岛β细胞来研究Munc13-1与Epac2和PKA之间的功能相互作用。GLP-1对Munc13-1(+/-)胰岛的刺激通过其对完整胰岛cAMP产生以及正常Epac2和Rim2水平的作用,使减少的双相胰岛素分泌恢复正常。
为了确定Epac2和PKA挽救由Munc13-1缺陷引起的哪些胞吐步骤,我们使用膜片钳电容测量,结果显示:1)cAMP恢复了Munc13-1(+/-)β细胞中减少的易释放池(RRP),并部分恢复了可释放囊泡池的再填充;2)Epac选择性激动剂[8-(4-氯苯硫基)-2'-O-甲基腺苷-3',5'-环一磷酸]部分恢复了减少的RRP和可释放囊泡池的再填充;3)用H89阻断PKA(使Epac保持完整)损害了cAMP恢复RRP和可释放囊泡池再填充的能力。相反,PKA选择性激动剂(N(6)-苯甲酰腺苷-cAMP)完全恢复了RRP,并部分恢复了可释放囊泡池的再填充。为了确定Epac-Rim2-Munc13-1相互作用位点内对cAMP挽救由Munc13-1缺陷引起的胞吐作用的具体贡献,我们发现用Rim-Munc13-1结合域肽阻断Rim2-Munc13-1相互作用消除了cAMP的挽救作用,而用Rim2-PDZ肽阻断Epac-Rim2相互作用仅适度减少再填充,对RRP影响很小。
cAMP通过Epac和PKA信号通路挽救由Munc13-1缺陷引起的引发缺陷需要下游的Munc13-1-Rim2相互作用。